成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
上海一飛生物科技有限公司 Company Information
Company Name:
Shanghai Yifei Biotechnology Co. , Ltd.
Tel:
021-65675885
Email:
customer_service@efebio.com
Nationality:
China
WebSite:
http://www.efebio.com
Product List:
11974
112
113
114
115
116
117
118
119
120
Product List
Thalidomide-4-NH-PEG1-NH2 TFA
2490499-21-1
Thalidomide-4-NH-PEG1-NH-Boc
2154342-17-1
JYS003
2361119-87-9
Ergosinine
596-88-3
Erlizumab
211323-03-4
2,6-Diethylnaphthalene
59919-41-4
Thalidomide-NH-(CH2)2-NH-Boc
1957235-57-2
Roledumab
1174008-79-7
Bimagrumab
1356922-05-8
Vandortuzumab
1471985-92-8
Dezamizumab
1662664-56-3
Ieramilimab
2137049-37-5
2,3,4-Trichlorophenol acetate
61925-89-1
Capromab
145464-28-4
Derlotuximab
340013-96-9
Landogrozumab
1391726-30-9
Vadastuximab
1436390-63-4
Ivuxolimab
2225940-98-5
Indatuximab
1238517-16-2
JYS006
2409007-41-4
Oportuzumab
945228-48-8
Denintuzumab
1399672-02-6
Olendalizumab
1337966-73-0
Balstilimab
2230167-06-1
Thalidomide-NH-CH2-COO(t-Bu)
2093386-23-1
Zolimomab
141483-72-9
Narnatumab
1188275-92-4
Coltuximab
1269764-99-9
Ontamalimab
2098790-40-8
Cibisatamab
2101242-53-7
Sudan Black B Impurity 1
65322-64-7
Thalidomide-NH-(CH2)3-NH-Boc
2093386-36-6
Biciromab
138783-13-8
6-Nitrobenz[a]pyrene
63041-90-7
Romosozumab
909395-70-6
Tacatuzumab
476413-07-7
Actoxumab
1245634-25-6
Refanezumab
1233953-61-1
Cusatuzumab
1399546-01-0
Tabituximab
1644134-10-0
caffeic acid glucoside
892501-29-0
Satumomab
144058-40-2
JYS002
1448189-66-9
Ertumaxomab
509077-99-0
Mapatumumab
658052-09-6
Besilesomab
537694-98-7
Alacizumab
934216-54-3
Domagrozumab
1629605-31-7
Apamistamab
2097132-02-8
Sirtratumab
1824663-82-2
PBB-No. 49
60044-24-8
2,2',5-Tribromobiphenyl
59080-34-1
Otlertuzumab
1372645-37-8
Pateclizumab
1202526-59-7
Evinacumab
1446419-85-7
4-Cyano-4'-undecylbiphenyl
65860-74-4
Naptumomab Estafenatox
676258-98-3
Dinutuximab
1363687-32-4
Radretumab
1253180-81-2
Ifabotuzumab
1234137-51-9
Samrotamab
2052591-32-7
Tamrintamab
2148325-59-9
Thalidomide-4-NH-PEG3-NH-Boc
2204246-03-5
4'-Cyano-4-nonyloxybiphenyl
58932-13-1
JYS009
2827750-25-2
Tositumomab
208921-02-2
Carbophenothion-methyl-sulfone
62059-34-1
1,2-Dichlorobutane
616-21-6
Oregovomab
213327-37-8
HuCC49
823788-82-5
Perakizumab
1331830-76-2
Clivatuzumab
1462876-11-4
Thalidomide-4-O-CH2-COO(t-Bu)
1950635-36-5
Testosterone-d4
638163-36-7
Thalidomide-5-NH-CH2-COO(t-Bu)
2412056-28-9
PBB No. 26
59080-35-2
JYS008
2827750-24-1
Glucuronic Acid
576-37-4
Arcitumomab
154361-48-5
VH032-NH-CO-CH2-NHBoc
2010986-19-1
Thalidomide-5-O-CH2-COO(t-Bu)
2682112-10-1
5,10,15,20-Tetraoxatetracosane-1,24-diol
61136-08-1
JYS005
2306389-02-4
3,4,5-Trichlorophenol acetate
59190-61-3
Clothianidin-urea
634192-72-6
VH032-NH-CO-CH2-Br
2379404-33-6
Thalidomide-4-NH-PEG2-COO(t-Bu)
2140807-16-3
PCB No. 50
62796-65-0
Nacolomab Tafenatox
150631-27-9
Lintuzumab
166089-32-3
JYS001
2111829-84-4
PBB No. 53
60044-25-9
Imciromab
126132-83-0
Stamulumab
705287-60-1
Ecromeximab
292819-64-8
JYS004
2412055-00-4
Thalidomide-4-NH-PEG1-COO(t-Bu)
2140807-19-6
Nofetumomab
165942-79-0
JYS007
2162120-75-2
Altumomab
156586-92-4
112
113
114
115
116
117
118
119
120
Copyright 2007© ChemicalBook. All rights reserved.